Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study

NCT06607302 · clinicaltrials.gov ↗
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

iOMEDICO AG

Collaborators